📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Genome editing for primary immunodeficiencies: A therapeutic perspective on Wiskott-Aldrich syndrome. (2022)

First Author: Naseem A

Attributed to: Development of a CRISPR/Cas9 gene editing platform to correct Severe Combined Immunodeficiency caused by mutations in the IL7RA gene funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2022.966084

PubMed Identifier: 36059471

Publication URI: http://europepmc.org/abstract/MED/36059471

Type: Journal Article/Review

Volume: 13

Parent Publication: Frontiers in immunology

ISSN: 1664-3224